Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Clinical Study Proves that EndyMed's Intensif Smooth Motion, Non-Insulated Microneedle Radiofrequency Application is an Effective Treatment for Depressed Acne Scars
  • USA - English


News provided by

EndyMed Medical, Ltd.

Jul 28, 2014, 10:00 ET

Share this article

Share toX

Share this article

Share toX


Caesarea, Israel (PRWEB) July 28, 2014 -- The Journal of Cosmetics, Dermatological Sciences and Applications published in its June 2014 edition a study performed by Israeli Board Certified Dermatologists, Dr. Yoram Harth and Dr. Monica Elman, that examines the safety and efficacy of EndyMed’s new Microneedle Radiofrequency handpiece in the treatment of patients with depressed acne scars.

EndyMed's specially designed smooth motion electronically controlled motor and high quality gold plated needles ensures minimal trauma to the epidermis and significantly decreases discomfort to the patient.

Post this

Twenty patients, fifteen females and five males, were included in the study. The mean age of the participants was 32.6 years. The number of treatments varied between one and six, with an average of 3.3 treatments per patient. The objective evaluation of the patient's improvement showed clear improvement in 95% of patients. Twenty five percent of the participants showed excellent improvement (defined as >75% improvement), an additional 50% experienced good improvement (defined as 26% - 50% improvement), and 20% showed minimal improvement. One patient showed no improvement. None of the patients experienced worsening in their skin condition.

When the patients were asked their opinion about their improvement, 19 out of 20 (95%) of the treated patients reported that they experienced some improvement. Twenty five percent reported that they experienced very good to excellent improvement (defined as >50% improvement), and an additional 30% reported good improvement (defined as 26% - 50% improvement). The rest reported some improvement (up to 25%). Only one patient did not notice any improvement.

The Intensif treatments were very well tolerated by the patients. Using a topical anesthetic cream before the treatment, eleven patients (55%) reported none to minimal pain, six (30%) moderate discomfort and only 3 (15%) reported significant pain.

Combining microneedles with radiofrequency is a skin treatment that is gaining popularity and offers multiple advantages over fractional lasers. As a group , RF microneedles systems allow for significantly deeper penetration of energy into the dermis with a decreased risk of downtime or risk of pigmentary changes in dark skin individuals. The FDA cleared Intensif handpiece by Endymed uses the latest in innovative Microneedle RF technology, and allows for controlled heating to a pre-defined depth (up to 3.5mm) of the dermis without epidermal coagulation. This eliminates most of the micro crusting, reduces the risk of post-inflammatory hyperpigmentation associated with epidermal injury, and allows for the return to normal routine after 24 hours or less.

EndyMed's specially designed smooth motion electronically controlled motor and high quality gold plated needles ensures minimal trauma to the epidermis and significantly decreases discomfort to the patient. These features offer clinical advantages over available fractional lasers and other Microneedle RF technologies.

The presented results prove that EndyMed's microneedle RF technology with electronically controlled smooth insertion motor and non-insulated gold plated needles is a completely safe and effective treatment option for atrophic acne scars, providing a minimally invasive, minimal discomfort and minimal downtime for all skin types. This study shows high objective and subjective satisfaction rates with minimal downtime or adverse effects.

The full article can be found on: http://www.scirp.org/journal/PaperDownload.aspx?paperID=47403.

About EndyMed Medical

EndyMed Medical Ltd., established in 2007, offers energy based aesthetic treatment systems for the professional markets. EndyMed's proprietary 3DEEP® radiofrequency technology is a unique multifunction treatment platform for fractional Skin resurfacing , Microneedle RF technology and non-ablative skin tightening on both the face and body. Through the three dimensional interaction of multiple RF sources, 3DEEP® RF creates deep thermal patterns in the tissue which is a novel and effective approach to aesthetic treatments. For more information, please see our website at http://www.endymed.com.

Tammy Weisman Maman, EndyMed Medical, Ltd., http://www.endymed.com, +972 577750036, [email protected]

Modal title

The Intensif Brochure
View PDF
The Intensif Brochure
The Intensif Patient Pamphlet
View PDF
The Intensif Patient Pamphlet
The Intensif Handpiece by EndyMed
The Intensif Handpiece by EndyMed
EndyMed's innovative, FDA cleared 3DEEP Radiofrequency Technology
View PDF
EndyMed's innovative, FDA cleared 3DEEP Radiofrequency Technology
The Intensif Handpiece by EndyMed microneedles
The Intensif Handpiece by EndyMed microneedles
The Intensif Brochure The Intensif Patient Pamphlet The Intensif Handpiece by EndyMed EndyMed's innovative, FDA cleared 3DEEP Radiofrequency Technology The Intensif Handpiece by EndyMed microneedles

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.